Acute Myeloid Leukemia

被引：132

作者：

Rubnitz, Jeffrey E. ^{[1
]}

Gibson, Brenda ^{[2
]}

Smith, Franklin O. ^{[3
]}

机构：

[1] St Jude Childrens Res Hosp, Dept Oncol, Memphis, TN 38105 USA

[2] Royal Hosp Sick Children, Dept Paediat Haematol, Glasgow G3 8SJ, Lanark, Scotland

[3] Univ Cincinnati, Coll Med, Cincinnati Childrens Hosp, Med Ctr,Div Hematol Oncol, Cincinnati, OH 45221 USA

来源：

HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA | 2010年 / 24卷 / 01期

关键词：

Myeloid; Leukemia; Childhood; MINIMAL RESIDUAL DISEASE; INTERNAL TANDEM DUPLICATION; BONE-MARROW-TRANSPLANTATION; ACUTE-MYELOGENOUS-LEUKEMIA; CHILDRENS-CANCER-GROUP; ACUTE PROMYELOCYTIC LEUKEMIA; PEDIATRIC-ONCOLOGY-GROUP; HIGH-DOSE CYTARABINE; AMEGAKARYOCYTIC THROMBOCYTOPENIC PURPURA; ACUTE MEGAKARYOBLASTIC LEUKEMIA;

D O I：

10.1016/j.hoc.2009.11.008

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Acute myeloid leukemia (AML) is a heterogeneous group of leukemias that result from clonal transformation of hematopoietic precursors through the acquisition of chromosomal rearrangements and multiple gene mutations. As a result of highly collaborative clinical research by pediatric cooperative cancer groups worldwide, disease-free survival has improved significantly during the past 3 decades. Further improvements in outcomes of children who have AML probably will reflect continued progress in understanding the biology of AML and the concomitant development of new molecularly targeted agents for use in combination with conventional chemotherapy drugs.

引用

页码：35 / +

页数：30

共 50 条

[21] Role of nucleophosmin in acute myeloid leukemia
Meani, Natalia
Alcalay, Myriam
EXPERT REVIEW OF ANTICANCER THERAPY, 2009, 9 (09) : 1283 - 1294
[22] Molecular diagnosis of acute myeloid leukemia
Watt, Christopher D.
Bagg, Adam
EXPERT REVIEW OF MOLECULAR DIAGNOSTICS, 2010, 10 (08) : 993 - 1012
[23] Conditioning regimens in acute myeloid leukemia
Visani, Giuseppe
Malagola, Michele
Guiducci, Barbara
Lucesole, Moira
Loscocco, Federica
Gabucci, Elisa
Paolini, Stefania
Piccaluga, Pier Paolo
Isidori, Alessandro
EXPERT REVIEW OF HEMATOLOGY, 2014, 7 (04) : 465 - 479
[24] Murine Models of Acute Myeloid Leukemia
Kurtz, Kristen J.
Conneely, Shannon E.
O'Keefe, Madeleine
Wohlan, Katharina
Rau, Rachel E.
FRONTIERS IN ONCOLOGY, 2022, 12
[25] Spontaneous remission of acute myeloid leukemia
Rashidi, Armin
Fisher, Stephen I.
LEUKEMIA & LYMPHOMA, 2015, 56 (06) : 1727 - 1734
[26] Gemtuzumab ozogamicin in acute myeloid leukemia: past, present and future
Gottardi, Michele
Sperotto, Alessandra
Di Rora, Andrea Ghelli Luserna
Padella, Antonella
Cangini, Delia
Giannini, Maria B.
Simonetti, Giorgia
Martinelli, Giovanni
Cerchione, Claudio
MINERVA MEDICA, 2020, 111 (05) : 395 - 410
[27] Emerging molecular predictive and prognostic factors in acute myeloid leukemia
McCurdy, Shannon R.
Levis, Mark J.
LEUKEMIA & LYMPHOMA, 2018, 59 (09) : 2021 - 2039
[28] The Past, Present and Future Subclassification of Patients with Acute Myeloid Leukemia
Forthun, Rakel B.
Hinrichs, Carina
Dowling, Tara H.
Bruserud, Oystein
Selheim, Frode
CURRENT PHARMACEUTICAL BIOTECHNOLOGY, 2015, 17 (01) : 6 - 19
[29] Clinical implications of molecular genetic aberrations in acute myeloid leukemia
Scholl, Sebastian
Fricke, Hans-Joerg
Sayer, Herbert G.
Hoeffken, Klaus
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2009, 135 (04) : 491 - 505
[30] Current Approaches in the Treatment of Relapsed and Refractory Acute Myeloid Leukemia
Ramos, Nestor R.
Mo, Clifton C.
Karp, Judith E.
Hourigan, Christopher S.
JOURNAL OF CLINICAL MEDICINE, 2015, 4 (04) : 665 - 695

← 1 2 3 4 5 →